SkinPen® Precision Now Available through DUBIMED in the Gulf States
DALLAS, April 5, 2024 /PRNewswire/ -- Crown Aesthetics ("Crown"), a division of Crown Laboratories, Inc., is happy to announce that SkinPen® Precision ("SkinPen"), the first microneedling device cleared by the FDA and a global leader in skin remodeling, is now available through DUBIMED Medical Supplies Trading LLC in United Arab Emirates, Qatar, and Oman.
- Access to SkinPen will significantly benefit these Gulf States countries' healthcare professionals and their customers.
- "At DUBIMED, we stand as leaders in the Gulf Cooperation Council for more than 37 years and are committed to bringing cutting-edge aesthetics medical solutions to these markets," said Safi Rajab, CEO of DUBIMED.
- FDA cleared in 2018 and backed by over 90 validation studies*, SkinPen Precision is a superior skin remodeling device engineered in the USA.
- Please visit www.skinpeninternational.com
SkinPen Precision works by creating controlled micro-injuries to stimulate the body's natural wound-healing response and remodel scar tissue.